Matsumoto T - Search Results

1

The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2.

Higa Y, Hiasa M, Tenshin H, Nakaue E, Tanaka M, Kim S, Nakagawa M, Shimizu S, Tanimoto K, Teramachi J, Harada T, Oda A, Oura M, Sogabe K, Hara T, Sumitani R, Maruhashi T, Yamagami H, Endo I, Matsumoto T, Tanaka E, Abe M. Higa Y, et al. Among authors: matsumoto t. Antioxidants (Basel). 2023 Jan 5;12(1):133. doi: 10.3390/antiox12010133. Antioxidants (Basel). 2023. PMID: 36670994 Free PMC article.

2

Apoptosis-related changes in skeletal muscles of patients with mitochondrial diseases.

Umaki Y, Mitsui T, Endo I, Akaike M, Matsumoto T. Umaki Y, et al. Among authors: matsumoto t. Acta Neuropathol. 2002 Feb;103(2):163-70. doi: 10.1007/s004010100446. Epub 2001 Oct 31. Acta Neuropathol. 2002. PMID: 11810183

3

Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma.

Abe M, Hiura K, Wilde J, Moriyama K, Hashimoto T, Ozaki S, Wakatsuki S, Kosaka M, Kido S, Inoue D, Matsumoto T. Abe M, et al. Among authors: matsumoto t. Blood. 2002 Sep 15;100(6):2195-202. Blood. 2002. PMID: 12200385 Free article.

4

Diurnal fluctuation of edema synchronized with plasma VEGF concentration in a patient with POEMS syndrome.

Endo I, Mitsui T, Nishino M, Oshima Y, Matsumoto T. Endo I, et al. Among authors: matsumoto t. Intern Med. 2002 Dec;41(12):1196-8. doi: 10.2169/internalmedicine.41.1196. Intern Med. 2002. PMID: 12521215 Free article.

5

Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors.

Endo I, Inoue D, Mitsui T, Umaki Y, Akaike M, Yoshizawa T, Kato S, Matsumoto T. Endo I, et al. Among authors: matsumoto t. Endocrinology. 2003 Dec;144(12):5138-44. doi: 10.1210/en.2003-0502. Epub 2003 Aug 13. Endocrinology. 2003. PMID: 12959989

6

Ability of myeloma cells to secrete macrophage inflammatory protein (MIP)-1alpha and MIP-1beta correlates with lytic bone lesions in patients with multiple myeloma.

Hashimoto T, Abe M, Oshima T, Shibata H, Ozaki S, Inoue D, Matsumoto T. Hashimoto T, et al. Among authors: matsumoto t. Br J Haematol. 2004 Apr;125(1):38-41. doi: 10.1111/j.1365-2141.2004.04864.x. Br J Haematol. 2004. PMID: 15015966 Free article.

7

[Biochemical markers in bone metastasis].

Hashimoto T, Abe M, Matsumoto T. Hashimoto T, et al. Among authors: matsumoto t. Gan To Kagaku Ryoho. 2004 Jul;31(7):1027-33. Gan To Kagaku Ryoho. 2004. PMID: 15272580 Review. Japanese.

8

Isolated cranial neuropathy associated with anti-glycolipid antibodies.

Kunishige M, Mitsui T, Yoshino H, Asano A, Tsuruo M, Endo I, Yagi F, Matsumoto T. Kunishige M, et al. Among authors: matsumoto t. J Neurol Sci. 2004 Oct 15;225(1-2):51-5. doi: 10.1016/j.jns.2004.06.017. J Neurol Sci. 2004. PMID: 15465085

9

Delayed motor and sensory neuropathy in a patient with brainstem encephalitis.

Chikakiyo H, Kunishige M, Yoshino H, Asano A, Sumitomo Y, Endo I, Matsumoto T, Mitsui T. Chikakiyo H, et al. Among authors: matsumoto t. J Neurol Sci. 2005 Jul 15;234(1-2):105-8. doi: 10.1016/j.jns.2005.02.011. J Neurol Sci. 2005. PMID: 15936038

10

Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2.

Oshima T, Abe M, Asano J, Hara T, Kitazoe K, Sekimoto E, Tanaka Y, Shibata H, Hashimoto T, Ozaki S, Kido S, Inoue D, Matsumoto T. Oshima T, et al. Among authors: matsumoto t. Blood. 2005 Nov 1;106(9):3160-5. doi: 10.1182/blood-2004-12-4940. Epub 2005 Jul 19. Blood. 2005. PMID: 16030194 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10,017 results

Search Page